The effect of FABP2 promoter haplotype on response to a diet with medium-chain triacylglycerols

Genes and Nutrition

Volumn 7, Issue 3, 2012, Pages 437-445

  Rubin, Diana ^a,b,c   Helwig, Ulf ^a,c   Pfeuffer, Maria ^a   Auinger, Annegret ^a   Ruether, Andreas ^d   Matusch, Dennis ^a   Darabaneanu, Stephanie ^c   Freitag Wolf, Sandra ^c   Nothnagel, Michael ^c   Schreiber, Stefan ^c,d   Schrezenmeir, Jürgen ^a  

^a FEDERAL RESEARCH INSTITUTE OF NUTRITION AND FOOD   (Germany)

^b FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

Author keywords

FABP2; Gene diet interaction; MCT; Mutation; Polymorphism; Postprandial metabolism; Promoter; SNP

Indexed keywords

CHYLOMICRON; FATTY ACID BINDING PROTEIN 2; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; FATTY ACID BINDING PROTEIN 2 GENE; GENE; GENE FUNCTION; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; HUMAN EXPERIMENT; LIPID DIET; MALE; NORMAL HUMAN; NUTRIGENOMICS; PROMOTER REGION;

EID: 84866053245     PISSN: 15558932     EISSN: 18653499     Source Type: Journal    
DOI: 10.1007/s12263-012-0280-z     Document Type: Article

References (37)

1. Agren JJ, Valve R, Vidgren H, Laakso M, Uusitupa M (1998) Postprandial lipemic response is modified by the polymorphism at codon 54 of the fatty acid-binding protein 2 gene. Arterioscler Thromb Vasc Biol 18:1606-1610 (Pubitemid 28465413)
2. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539-553 (Pubitemid 28319935)
3. Asakura L, Lottenberg AM, Neves MQ, Nunes VS, Rocha JC, Passarelli M, Nakandakare ER, Quintao EC (2000) Dietary medium-chain triacylglycerol prevents the postprandial rise of plasma triacylglycerols but induces hypercholesterolemia in primary hypertriglyceridemic subjects. Am J Clin Nutr 71:701-705 (Pubitemid 30118561)
4. Bach AC, Ingenbleek Y, Frey A (1996) The usefulness of dietary medium-chain triglycerides in body weight control: fact or fancy? J Lipid Res 37:708-726 (Pubitemid 26140809)
5. Baier LJ, Sacchettini JC, Knowler WC, Eads J, Paolisso G, Tataranni PA, Mochizuki H, Bennett PH, Bogardus C, Prochazka M (1995) An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance. J Clin Invest 95:1281-1287
6. Ball MJ (1993) Parenteral nutrition in the critically ill: use of a medium chain triglyceride emulsion. Intensive Care Med 19:89-95 (Pubitemid 23114206)
7. Binnert C, Pachiaudi C, Beylot M, Hans D, Vandermander J, Chantre P, Riou JP, Laville M (1998) Influence of human obesity on the metabolic fate of dietary long- and medium-chain triacylglycerols. Am J Clin Nutr 67:595-601 (Pubitemid 28153160)
8. Chambers E, Godwin SL, Vecchio FA (2000) Cognitive strategies for reporting portion sizes using dietary recall procedures. J Am Diet Assoc 100:891-897
9. Damcott CM, Feingold E, Moffett SP, Barmada MM, Marshall JA, Hamman RF, Ferrell RE (2003) Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels. Hum Genet 112:610-616 (Pubitemid 36869056)
10. Dworatzek PD, Hegele RA, Wolever TM (2004) Postprandial lipemia in subjects with the threonine 54 variant of the fatty acid-binding protein 2 gene is dependent on the type of fat ingested. Am J Clin Nutr 79:1110-1117 (Pubitemid 41095965)
11. Eckel RH, Hanson AS, Chen AY, Berman JN, Yost TJ, Brass EP (1992) Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes 41:641-647
12. Formanack ML, Baier LJ (2004) Variation in the FABP2 promoter affects gene expression: implications for prior association studies. Diabetologia 47:349-351 (Pubitemid 38315373)
13. Geschonke K, Klempt M, Lynch N, Schreiber S, Fenselau S, Schrezenmeir J (2002) Detection of a promoter polymorphism in the gene of intestinal fatty acid binding protein (I-FABP). Ann NY Acad Sci 967:548-553 (Pubitemid 34721945)
14. Hampe J, Shaw SH, Saiz R, Leysens N, Lantermann A, Mascheretti S, Lynch NJ, MacPherson AJ, Bridger S, van Deventer S, Stokkers P, Morin P, Mirza MM, Forbes A, Lennard-Jones JE, Mathew CG, Curran ME, Schreiber S (1999) Linkage of inflammatory bowel disease to human chromosome 6p. Am J Hum Genet 65:1647-1655 (Pubitemid 30468677)
15. Han JR, Deng B, Sun J, Chen CG, Corkey BE, Kirkland JL, Ma J, Guo W (2007) Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism 56:985-991 (Pubitemid 46900838)
16. Hegele RA, Wolever TM, Story JA, Connelly PW, Jenkins DJ (1997) Intestinal fatty acid-binding protein variation associated with variation in the response of plasma lipoproteins to dietary fibre. Eur J Clin Invest 27:857-862 (Pubitemid 27460624)
17. Helwig U, Rubin D, Klapper M, Li Y, Nothnagel M, Folsch UR, Doring F, Schreiber S, Schrezenmeir J (2007) The association of fatty acid-binding protein 2 A54T polymorphism with postprandial lipemia depends on promoter variability. Metabolism 56:723-731 (Pubitemid 46734078)
18. Higashi K, Ishikawa T, Shige H, Tomiyasu K, Yoshida H, Ito T, Nakajima K, Yonemura A, Sawada S, Nakamura H (1997) Olive oil increases the magnitude of postprandial chylomicron remnants compared to milk fat and safflower oil. J Am Coll Nutr 16:429-434 (Pubitemid 27415504)
19. Hill JO, Peters JC, Yang D, Sharp T, Kaler M, Abumrad NN, Greene HL (1989) Thermogenesis in humans during overfeeding with medium-chain triglycerides. Metabolism 38:641-648 (Pubitemid 19174308)
20. Huang H, Starodub O, McIntosh A, Kier AB, Schroeder F (2002) Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem 277:29139-29151
21. Johnson RK, Driscoll P, Goran MI (1996) Comparison of multiplepass 24-hour recall estimates of energy intake with total energy expenditure determined by the doubly labeled water method in young children. J Am Diet Assoc 96:1140-1144 (Pubitemid 27381760)
22. Li Y, Fisher E, Klapper M, Boeing H, Pfeiffer A, Hampe J, Schreiber S, Burwinkel B, Schrezenmeir J, Doring F (2006) Association between functional FABP2 promoter haplotype and type 2 diabetes. Horm Metab Res 38:300-307 (Pubitemid 43864950)
23. Lowe JB, Sacchettini JC, Laposata M, McQuillan JJ, Gordon JI (1987) Expression of rat intestinal fatty acid-binding protein in Escherichia coli. Purification and comparison of ligand binding characteristics with that of Escherichia coli-derived rat liver fatty acid-binding protein. J Biol Chem 262:5931-5937
24. Marin C, Perez-Jimenez F, Gomez P, Delgado J, Paniagua JA, Lozano A, Cortes B, Jimenez-Gomez Y, Gomez MJ, Lopez- Miranda J (2005) The Ala54Thr polymorphism of the fatty acidbinding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat. Am J Clin Nutr 82:196-200 (Pubitemid 41716393)
25. Marten B, Pfeuffer M, Schrezenmeir J (2006) Medium-chain triglycerides. Int Diary J 16:1374-1382 (Pubitemid 44331591)
26. Mekki N, Charbonnier M, Borel P, Leonardi J, Juhel C, Portugal H, Lairon D (2002) Butter differs from olive oil and sunflower oil in its effects on postprandial lipemia and triacylglycerol-rich lipoproteins after single mixed meals in healthy young men. J Nutr 132:3642-3649 (Pubitemid 35435041)
27. Mills GLLP, Weech PK (1989) A guidebook to lipoprotein technique. In: Burdon RH, van Knippenberg PH (eds) Laboratory techniques in biochemistry and molecular biology, vol 14. Elsevier, Amsterdam
28. Nosaka N, Maki H, Suzuki Y, Haruna H, Ohara A, Kasai M, Tsuji H, Aoyama T, Okazaki M, Igarashi O, Kondo K (2003) Effects of margarine containing medium-chain triacylglycerols on body fat reduction in humans. J Atheroscler Thromb 10:290-298
29. Oikari S, Ahtialansaari T, Huotari A, Kiehne K, Fölsch UR, Wolffram S, Jänne J, Alhonen L, Herzig KH (2008) Effect of medium- and long-chain fatty acid diets on PPAR and SREBP-1 expression and glucose homeostasis in ACBP-overexpressing transgenic rats. Acta Physiol (Oxf)194:57-65
30. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789
31. Richieri GV, Ogata RT, Kleinfeld AM (1994) Equilibrium constants for the binding of fatty acids with fatty acid-binding proteins from adipocyte, intestine, heart, and liver measured with the fluorescent probe ADIFAB. J Biol Chem 269:23918-23930
32. Richieri GV, Ogata RT, Zimmerman AW, Veerkamp JH, Kleinfeld AM (2000) Fatty acid binding proteins from different tissues show distinct patterns of fatty acid interactions. Biochemistry 39:7197-7204 (Pubitemid 30413109)
33. Rubin D, Helwig U, Nothnagel M, Lemke N, Schreiber S, Folsch UR, Doring F, Schrezenmeir J (2008) Postprandial plasma adiponectin decreases after glucose and high fat meal and is independently associated with postprandial triacylglycerols but not with - 11388 promoter polymorphism. Br J Nutr 99:76-82 (Pubitemid 350286141)
34. Rubin D, Helwig U, Nothnagel M, Folsch UR, Schreiber S, Schrezenmeir J (2010) Association of postprandial and fasting triglycerides with traits of the metabolic syndrome in the Metabolic Intervention Cohort Kiel. Eur J Endocrinol 162:719-727
35. Tholstrup T, Ehnholm C, Jauhiainen M, Petersen M, Hoy CE, Lund P, Sandstrom B (2004) Effects of medium-chain fatty acids and oleic acid on blood lipids, lipoproteins, glucose, insulin, and lipid transfer protein activities. Am J Clin Nutr 79:564-569 (Pubitemid 41103898)
36. Van Wymelbeke V, Louis-Sylvestre J, Fantino M (2001) Substrate oxidation and control of food intake in men after a fat-substitute meal compared with meals supplemented with an isoenergetic load of carbohydrate, long-chain triacylglycerols, or mediumchain triacylglycerols. Am J Clin Nutr 74:620-630 (Pubitemid 33015148)
37. Yonezawa T, Yonekura S, Sanosaka M, Hagino A, Katoh K, Obara Y (2004) Octanoate stimulates cytosolic triacylglycerol accumulation and CD36 mRNA expression but inhibits acetyl coenzyme A carboxylase activity in primary cultured bovine mammary epithelial cells. J Dairy Res 71:398-404 (Pubitemid 39606359)